Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

1.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.4K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

2.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
2.1K
Bone Structure01:55

Bone Structure

51.9K
Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
51.9K
Bone Remodeling01:40

Bone Remodeling

40.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.5K
Compact Bone01:27

Compact Bone

16.8K
Most bones contain compact and spongy osseous tissue, but their distribution and concentration vary based on the bone's overall function.
Compact bone, also called cortical bone, is the denser, stronger of the two types of bone tissue. It is found under the periosteum and in the diaphyses of long bones, where it provides support and protection. The microscopic structural unit of compact bone is called an osteon, or haversian system. Each osteon is composed of concentric rings of calcified...
16.8K
Bone Disorders01:29

Bone Disorders

5.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-emptive versus empirical antifungal therapy in patients with febrile neutropenia with acute leukaemia: a GIMEMA study.

JAC-antimicrobial resistance·2026
Same author

Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT.

Frontiers in immunology·2026
Same author

Clinical and prognostic significance of concomitant autoimmune disease in patients with myelofibrosis.

Annals of hematology·2026
Same author

A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib.

Blood advances·2026
Same author

Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT.

American journal of hematology·2026
Same author

Refractory immune cytopenia successfully treated with mycophenolate mofetil in four adolescents with del22q11.2 syndrome.

Frontiers in immunology·2026

Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Developing a Reproducible Method for Isolating Bone Marrow-Derived Macrophages from Neonatal Mice to Advance Early Life Immune Responses
06:53

Author Spotlight: Developing a Reproducible Method for Isolating Bone Marrow-Derived Macrophages from Neonatal Mice to Advance Early Life Immune Responses

Published on: May 24, 2024

3.0K

Iron toxicity - Its effect on the bone marrow.

Alessandro Isidori1, Lorenza Borin2, Elena Elli2

  • 1Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Pesaro, Italy.

Blood Reviews
|April 28, 2018
PubMed
Summary

Excess iron harms bone marrow by increasing oxidative stress and disrupting blood cell formation. Iron chelation therapy, like deferasirox, may protect against this toxicity and improve blood cell production.

Keywords:
Aplastic anemiaBone marrow microenvironmentHematopoietic stem cell transplantationIron chelationIron toxicityMyelodysplastic syndromeMyelofibrosis

More Related Videos

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.0K
Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

75.4K

Related Experiment Videos

Last Updated: Feb 11, 2026

Author Spotlight: Developing a Reproducible Method for Isolating Bone Marrow-Derived Macrophages from Neonatal Mice to Advance Early Life Immune Responses
06:53

Author Spotlight: Developing a Reproducible Method for Isolating Bone Marrow-Derived Macrophages from Neonatal Mice to Advance Early Life Immune Responses

Published on: May 24, 2024

3.0K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.0K
Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

75.4K

Area of Science:

  • Hematology
  • Toxicology
  • Molecular Biology

Background:

  • Excess iron is toxic, potentially causing organ damage without chelation therapy.
  • Iron toxicity impacts bone marrow by increasing reactive oxygen species and disrupting hematopoiesis.
  • Deferasirox, an iron chelator, shows potential in mitigating iron toxicity effects on the hematopoietic system.

Purpose of the Study:

  • To review the mechanisms of free iron toxicity in the bone marrow.
  • To explore the impact of iron toxicity on the hematopoietic microenvironment.
  • To discuss the potential role of deferasirox in counteracting iron-induced bone marrow damage.

Main Methods:

  • Literature review of preclinical studies on iron toxicity and bone marrow function.
  • Analysis of studies investigating deferasirox's effects on hematopoiesis.
  • Synthesis of current knowledge on iron metabolism and its impact on the hematopoietic microenvironment.

Main Results:

  • Iron toxicity generates reactive oxygen species, affecting gene expression related to hematopoiesis.
  • Iron chelation with deferasirox can partially reverse these detrimental effects.
  • Deferasirox may induce hematological responses and reduce transfusion dependency, though mechanisms are unclear.

Conclusions:

  • Free iron poses a significant risk to bone marrow function and the hematopoietic microenvironment.
  • Iron chelation therapy, particularly with deferasirox, offers a potential therapeutic strategy.
  • Further research is needed to elucidate the precise mechanisms by which deferasirox influences hematopoiesis in iron-overloaded states.